Skip to content. | Skip to navigation

University of Piemonte Orientale

Personal tools

You are here: Home / Teachers / Gianluca GAIDANO / Gianluca GAIDANO: List of publications

Navigation

Gianluca GAIDANO: List of publications

Selected publications of the last 10 years:

  1. Rossi D, Capello D, Gloghini A, Franceschetti S, Paulli M, Bhatia K, Saglio G, Vitolo U, Pileri SA, Esteller M, Carbone A, Gaidano G.
    ABERRANT PROMOTER METHYLATION OF MULTIPLE GENES THROUGHOUT THE CLINICO-PATHOLOGIC SPECTRUM OF B-CELL NEOPLASIA
    Haematologica 89:154-164, 2004
  2. Forconi F, Capello D, Berra E, Rossi D, Gloghini A, Cerri M, Muti G, Morra E, Paulli M, Magrini U, Lucioni M, Rambaldi A, Lauria F, Carbone A, Stevenson FK, Gaidano G.
    INCIDENCE OF NOVEL N-GLYCOSYLATION SITES IN THE B-CELL RECEPTOR OF LYMPHOMAS ASSOCIATED WITH IMMUNODEFICIENCY
    Br J Haematol 124:604-609, 2004
  3. Duval A, Raphael M, Brennetot C, Poirel H, Buhard O, Aubry A, Martin A, Krimi A, Leblon V, Gabarre J, Davi F, Charlotte F, Berger F, Gaidano G, Capello D, Canioni D, Bardessoule D, Fauillard J, Gaulard P, Delfau MH, Ferlicot S, Eclache V, Prevot S, Guettier C, Cornillet Lefevre P, Adotti F, Hamelin R.
    THE MUTATOR PHENOTYPE IS A FEATURE OF IMMUNODEFICIENCY-RELATED LYMPHOMAS
    Proc Natl Acad Sci USA 101:5002-5007, 2004
  4. Antonino Carbone, Annunziata Gloghini, Gaidano G.
    IS PLASMABLASTIC LYMPHOMA OF THE ORAL CAVITY AN HHV8 ASSOCIATED DISEASE?
    Am J Surg Pathol 28:1251-1252, 2004 (letter)
  5. Baudo F, De Cataldo F, Gaidano G.
    TREATMENT OF ACQUIRED FACTOR VIII INHIBITOR VIA RECOMBINANT ACTIVATED FACTOR VIIa: DATA FROM THE ITALIAN REGISTRY OF ACQUIRED HEMOPHILIA.
    Haematologica, 89:759-760, 2004 (letter)
  6. Ferreri AJM, Dell’Oro S, Capello D, Ponzoni M, Iuzzolino P, Rossi D, Pasini F, Ambrosetti A, Orvieto E, Ferrarese F, Arrigoni G, Foppoli M, Reni M, Gaidano G.
    ABERRANT METHYLATION IN THE PROMOTER REGION OF THE REDUCED FOLATE CARRIER GENE IS A POTENTIAL MECHANISM OF RESISTANCE TO METHOTREXATE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS
    Br J Haematol 126:657-664, 2004
  7. Hussain A, Gutierrez MI, Timson G, Siraj AK, Deambrogi C, Al-Rasheed M, Gaidano G, Magrath I, Bhatia K.
    FREQUENT SILENCING OF FRAGILE HISTIDINE TRIAD GENE (FHIT) IN BURKITT’s LYMPHOMA IS ASSOCIATED WITH ABERRANT HYPERMETHYLATION.
    Genes, Chromosomes & Cancer  41:321-329, 2004
  8. Cerri M, Capello D, Muti G, Rambaldi A, Paulli, M, Gloghini A, Berra E, Deambrogi C, Rossi D, Franceschetti S, Conconi A, Morra E, Pasqualucci L, Carbone A, Gaidano G.
    ABERRANT SOMATIC HYPERMUTATION IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
    Br J Haematol 127:362-364, 2004 (letter)
  9. Capello D, Guarini A, Berra E, Mauro FR, Rossi D, Ghia E, Cerri M, Logan J, Foà R, Gaidano G.
    EVIDENCE OF BIASED IMMUNOGLOBULIN VARIABLE GENE USAGE IN HIGHLY STABLE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA.
    Leukemia, 18:1941-1947, 2004
  10. Libra M, Capello D, Gloghini A, Pasqualucci L, Berra E, Cerri M, Gasparotto D, De Re V, Carbone A, Gaidano G, Carbone A.
    ANALYSIS OF ABERRANT SOMATIC HYPERMUTATION (SHM) IN NON-HODGKIN LYMPHOMAS OF PATIENTS WITH HCV INFECTION.
    J Pathol 206: 87-91, 2005
  11. Carbone A, Gloghini A, Vaccher E, Cerri M, Gaidano G, Dalla-Favera R, Tirelli U.
    KAPOSI’s SARCOMA-ASSOCIATED HERPESVIRUS/HUMAN HERPESVIRUS TYPE 8-POSITIVE SOLID LYMPHOMAS. A TISSUE-BASED VARIANT OF PRIMARY EFFUSION LYMPHOMA.
    J Mol Diagn  7: 17-27, 2005
  12. Carbone A, Gloghini A, Vaccher E, Marchetti G, Gaidano G, Tirelli U.
    KSHV/HHV8-ASSOCIATED LYMPH NODE-BASED LYMPHOMAS IN HIV-SERONEGATIVE SUBJECTS. REPORT OF TWO CASES WITH ANAPLASTIC LARGE CELL MORPHOLOHGY AND PLASMABLASTIC IMMUNOPHENOTYPE.
    J Clin Pathol 58: 1039-1045, 2005
  13. Sirianni MC, Libi F, Campagna M, Rossi D, Capello D, Sciaranghella G, Carbone A, Simonelli C, Monini P,  Gaidano G, Ensoli B.
    DOWN-REGULATION OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULES BY HUMAN HERPESVIRUS TYPE 8 AND IMPAIRED NATURAL KILLER CELL ACTIVITY IN PRIMARY EFFUSION LYMPHOMA DEVELOPMENT.
    Br J Haematol 130: 92-95, 2005
  14. Capello D, Rossi D,  Gaidano G.
    POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: MOLECULAR BASIS OF DISEASE HISTOGENESIS AND PATHOGENESIS.
    Hematol Oncol 23:61-67, 2005
  15. Rossi D, Cerri M, Capello D, Deambrogi C, Berra E, Franceschetti S, Alabiso O, Gloghini A, Palli M, Carbone A, Pileri SA, Pasqualucci L, Gaidano G.
    ABERRANT SOMATIC HYPERMUTATION IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
    Leukemia  19: 2363-2366, 2005
  16. Rinaldi A, Kwee I, Taborelli M, Largo C, Uccella S, Martin V, Poretti G,  Gaidano G, Calabrese G, Martinella G, Baldini L, Pruneri G, Capella C, Zucca E, Cotter FE, Cigudosa JC, Catalano CV, Tibiletti MG, Bertoni F.
    GENOMIC AND EXPRESSION PROFILING IDENTIFIES THE B CELL ASSOCIATED TYROSINE KINASE SYK AS A POSSIBLE THERAPEUTIC TARGET IN MANTLE CELL LYMPHOMA.
    Br J Haematol 132: 303-316, 2006
  17. Capello D, Zucchetto A, Degan M, Bomben R, Dal Bo M, Efremov DG, Laurenti L, Del Poeta G,  Gaidano G, Gattei V.
    IMMUNOPHENOTYPIC CHARACTERIZATION OF IGVH3-72 B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL).
    Leukemia Res,  30: 1197-1199, 2006
  18. Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Palli M, Morra E, Gambacorta M, Cortelazzo S, Tucci A, Ungari M, Ambrosetti A, Menestrina F, Orsucci L, Novero D, Pulsoni A, Frezzato M, Gaidano G, Vallisa D, Minardi V, Tripodo C, Callea V, Baldini L, Merli F, Federico M, Franco V, Iannitto E, for the Intergruppo Italiano Linfomi (IIL).
    SPLENIC MARGINAL ZONE LYMPHOMA: A PROGNOSTIC MODEL FOR CLINICAL USE.
    Blood 107:4643-4649, 2006
  19. Ascoli V, Calabrò ML, Giannakakis K, Barbierato M, Chieco-Bianchi L, Gastaldi R, Narciso P, Gaidano G, Capello D.
    KAPOSI’S SARCOMA-ASSOCIATED HERPESVIRUS/HUMAN HERPESVIRUS 8-ASSOCIATED POLYCLONAL BODY CAVITY EFFUSIONS THAT MIMIC PRIMARY EFFUSION LYMPHOMAS.
    Int J Cancer 119:1746-1748, 2006 
  20. Liso A, Capello D, Marafioti T, Tiacci E, Cerri M, Distler V, Palli, Carbone A, Del sol G, Campo E, Pileri S, Pasqualucci L, Gaidano G, Falini B.
    ABERRANT SOMATIC HYPERMUTATION IN TUMOR CELLS OF NODULAR LYMPHOCYTE-PREDOMINANT AND CLASSICAL HODGKIN’s LYMPHOMA.
    Blood 108: 1013-1020, 2006
  21. Rinaldi A, Kwee I, Poretti G, Mensah A, Pruneri G, Capello D, Rossi D, Zucca E, Punzoni M, Catapano C, Tibiletti MG, Paulli M, Gaidano G, Bertoni F.
    COMPARATIVE GENOME WIDE PROFILING OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND DIFFUSE LARGE B-CELL LYMPHOMAS.
    Br J Haematol 134:27-36, 2006
  22. Lucioni M, Capello D, Riboni R, Ippoliti G, Campana C, Bandiera L, Arcani L, Rossi D, Cerri M, Dionigi P, Lazzarino M, Magrini U, Vigano M, < span>Gaidano G, Paulli M.
    B-CELL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN HEART AND/OR LUNGS RECIPIENTS: CLINICAL AND MOLECULAR-HISTOGENETIC STUDY OF 17 CASES FROM A SINGLE INSTITUTION.
    Transplantation 82: 1013-1023, 2006
  23. Capello D, Cerri M, Muti G, Lucioni M, Oreste P, Gloghini A, Berra E, Deambrogi C, Franceschetti S, Rossi D, Alabiso O, Morra E, Rambaldi A, Carbone A, Paulli M, Gaidano G.
    ANALYSIS OF IMMUNOGLOBULIN HEAVY AND LIGHT CHAIN VARIABLE GENES IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS.
    Hematol Oncol  24:212-219, 2006                                                                               
  24. Rossi D, Deambrogi C, Capello D, Cerri M, Lunghi M, Parvis G, Saglio G, Gaidano G, Cilloni D.
    JAK2V617F MUTATION IN LEUKAEMIC TRANSFORMATION OF PHILADELPHIA NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS.
    Br J Haematol 135:267-268, 2006
  25. Rossi D, Berra E, Cerri M, Deambrogi C, Barbieri C, Franceschetti S, Lunghi M, Conconi A, Paulli M, Matolcsy A, Pasqualucci L, Capello D, Gaidano G.
    ABERRANT SOMATIC HYPERMUTATION IN TRANSFORMATION OF FOLLICULAR LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA TO DIFFUSE LARGE B-CELL LYMPHOMA.
    Haematologica/The Hematology Journal  91:1405-1409, 2006                    
  26. Ghiotto F, Fais F, Albesiano E, Sison C, Valetto A, Gaidano G, Reinhardt J, Kolitz JE, Rai K, Allen SL, Ferrarini M, Chiorazzi N.
    SIMILARITIES AND DIFFERENCES BETWEEN THE LIGHT AND HEAVY CHAIN Ig VARIABLE REGION GENE REPERTOIRES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Mol Med 12:300-308, 2006
  27. Rossi D, Cortini F, Deambrogi C, Barbieri C, Cerri M, Franceschetti S, Conconi A, Capello D, Gaidano G.
    USEFULNESS OF JAK2V617F MUTATION IN DISTINGUISHING IDIOPATHIC ERYTHROCYTOSIS FROM POLYCYTHEMIA VERA.
    Leuk Res  31:97-101, 2007
  28. Rossi D, Franceschetti S, Cerri M, Conconi A, Lunghi M, Capello D, Cantello R, Gaidano G.
    HAIRY CELL LEUKAEMIA COMPLICATED BY ANTI-MAG PARAPROTEINEMIC DEMYELINATING NEUROPATHY: RESOLUTION OF NEUROLOGICAL SYNDROME AFTER CLADRIBRINE TREATMENT.
    Leuk Res 31:873-876, 2007
  29. Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM.
    CHARACTERIZATION OF VARIANTS IN THE PROMOTER OF EBV GENE BZLF1 IN NORMAL DONORS, HIV POSITIVE PATIENTS AND IN AIDS-RELATED LYMPHOMAS.
    J Infection  54:298-306, 2007
  30. Lacrima K, Rinaldi A, Vignati S, Martin V, Tibiletti MG, Gaidano G, Catalano CV, Bertoni F.
    CYCLIN-DEPENDENT KINASE INHIBITOR SELICICLIB SHOWS IN VITRO ACTIVITY IN DIFFUSE LARGE B CELL LYMPHOMAS.
    Leuk Lymphoma 48:158-167,2007
  31. Rossi D, Franceschetti S, Capello D, Conconi A, Casadio C, Valente G, Gaidano G.
    SIMULTANEOUS DIAGNOSIS OF CD3+ T-CELL LARGE GRANULAR LYMPHOCYTE LEUKAEMIA AND TRUE THYMIC HYPERPLASIA.
    Leuk Res 31:1019-1021, 2007                                                                         
  32. Bomben R, Dal Bo M, Capello D, Benedetti D, Marconi D, Zucchetto A, Forconi F, Maffei R, Ghia EM, Laurenti L, Bulina P, Del Principe MI, Palermo G, Thorselius M, Degan M, Campanini R, Guarini A, Del Poeta G, Rosenquist R, Efremov DG, Marasca R, Foà R, Gaidano G, Gattei V.
    COMPREHENSIVE CHARACTERIZATION OF IGHV3-21-EXPRESSING B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: AN ITALIAN MULTICENTER STUDY.
    Blood 109:2989-2998, 2007             
  33. Rossi D, Franceschetti S, Capello D, De Paoli L, Lunghi M, Conconi A, Gaidano G.
    TRANSIENT MONOCLONAL EXPANSION OF CD8+/CD57+ T-CELL LARGE GRANULAR LYMPHOCYTES AFTER PRIMARY CYTOMEGALOVIRUS INFECTION.
    Am J Hematol 82:1103-1105, 2007
  34. Rossi D, De Paoli L, Franceschetti S, Capello D, Vendramin C, Lunghi M, Conconi A, Magnani C, Gaidano G.
    PREVALENCE AND CLINICAL CHARACTERISTICS OF IMMUNE THROMBOCYTOPENIC PURPURA IN A COHORT OF MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE.
    Br J Hematol 138:249-252, 2007
  35. Rossi D, Cresta S, Destro T, Vendramin C, Bocchetta S, De Paoli L, Cerri M, Lunghi M, Gaidano G.
    JAK2V617F IN IDIOPATHIC VENOUS THROMBOEMBOLISM OCCURRING IN THE ABSENCE OF INHERITED OR ACQUIRED THROMBOPHILIA.
    Br J Haematol 138:813-814, 2007 (letter)
  36. Rossi D, Gaidano G.
    NUCLEAR CD40 PROMOTES LYMPHOMA FROM NUCLEAR HIDEAWAY.
    Blood 110:1710-1711, 2007 (Inside Blood Editorial)
  37. Carbone A, Gloghini A, Gaidano G.
    KSHV/HHV8 DOES NOT PLAY A SIGNIFICANT ROLE IN THE DEVELOPMENT OF PLASMABLASTIC LYMPHOMA OF THE ORAL CAVITY.
    Am J Surg Pathol 32:172-174, 2008 (letter)
  38. Benedetti D, Bomben R, Dal Bo M, Marconi D, Zucchetto A, Degan M, Forconi F, Del Poeta G, Gaidano G, Gattei V.
    ARE SURROGATES OF IGHV GENE MUTATIONAL STATUS USEFUL IN B CELL CHRONIC LYMPHOCYTIC LEUKEMIA? THE EXAMPLE OF SEPTIN 10.
    Leukemia 22:224-226, 2008 
  39. Rossi D, Rasi S, Capello D, Gaidano G.
    PROGNOSTIC ASSESSMENT OF BCL2-938C>A POLYMORPHISM IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Blood 111:466-468, 2008 (letter)   
  40. Rossi D, Ramponi A, Franceschetti S, Stratta P, Gaidano G.
    BONE MARROW NECROSIS COMPLICATING POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER: RESOLUTION WITH RITUXIMAB.
    Leuk Res 32:829-834, 2008 
  41. Rossi D, De Paoli L, Rossi FM, Cerri M, Deambrogi C, Rasi S, Zucchetto A, Capello D, Gattei V, Gaidano G.
    EARLY STAGE CHRONIC LYMPHOCYTIC LEUKAEMIA CARRYING UNMUTATED IGHV GENES IS AT RISK OF RECURRENT INFECTIONS DURING WATCH AND WAIT.
    Br J Haematol 141:734-736, 2008
  42. Forconi F, Sozzi E, Rossi D, Sahota SS, Amato T, Raspadori D, Trentin L, Leoncini L, Gaidano G, Lauria F.
    SELECTIVE INFLUENCES IN THE EXPRESSED IMMUNOGLOBULIN HEAVY AND LIGHT CHAIN GENE REPERTOIRE IN HAIRY CELL LEUKEMIA.
    Haematologica/The Hematology Journal 93:697-705, 2008  
  43. Capello D, Deambrogi C, Rossi D, Lischetti T, Piranda D, Cerri M, Spina V, Rasi S, Gaidano G, Lunghi M.
    EPIGENETIC INACTIVATION OF SUPPRESSORS OF CYTOKINE SIGNALLING IN Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS.
    Br J Haematol 141:504-511, 2008
  44. Forconi F, Poretti G, Kwee I, Sozzi E, Rossi D, Rancoita P, Capello D, Rinaldi A, Zucca E, Raspadori D, Lauria F, Gaidano G, Bertoni F.
    HIGH DENSITY GENOME-WIDE DNA PROFILING REVEALS A REMARKABLY STABLE PROFILE IN HAIRY CELL LEUKAEMIA.
    Br J Haematol 141:622-630, 2008
  45. Rossi D, Cerri M, Capello D, Deambrogi C, Rossi FM, Zucchetto A, De Paoli L, Cresta S, Rasi S, Spina V, Franceschetti S, Lunghi M, Vendramin C, Bomben R, Ramponi A, Monga G, Conconi A, Magnani C, Gattei V, Gaidano G.
    BIOLOGICAL AND CLINICAL RISK FACTORS OF CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION TO RICHTER’s SYNDROME.
    Br J Haematol 142:202-215, 2008
  46. Aydin S, Rossi D, Bergui L, D’Arena G, Ferrero E, Bonello L, Omedé P, Novero D, Morabito F, Carbone A, Gaidano G, Malavasi F, Deaglio S.
    CD38 GENE POLYMORPHISM AND CHRONIC LYMPHOCYTIC LEUKEMIA: A ROLE IN TRANSFORMATION TO RICHTER’s SYNDROME?
    Blood 111:5646-5653, 2008
  47. Capello D, Martini M, Gloghini A, Cerri M, Rasi S, Deambrogi C, Rossi D, Spina M, Tirelli U, Larocca LM, Carbone A, Gaidano G.
    MOLECULAR ANALYSIS OF IMMUNOGLOBULIN VARIABLE GENES IN HIV-RELATED NON HODGKIN LYMPHOMA REVEALS IMPLICATIONS FOR DISEASE PATHOGENESIS AND HISTOGENESIS.
    Haematologica/The Hematology Journal 93:1178-1185, 2008
  48. Rossi D, Zucchetto A, Rossi FM, Capello D, Cerri M, Deambrogi C, Cresta S, Rasi S, De Paoli L, Lobetti Bodoni C, Bulian P, Del Poeta G, Ladetto M, Gattei V, Gaidano G.
    CD49d EXPRESSION IS AN INDEPENDENT RISK FACTOR OF PROGRESSIVE DISEASE IN EARLY STAGE OF CHRONIC LYMPHOCYTIC LEUKEMIA.
    Haematologica/The Hematology Journal 93:1575-1579, 2008
  49. Forconi F, Rinaldi A, Kwee I, Sozzi E, Raspadori D, Rancoita P, Rossi D, Deambrogi C, Capello D, Zucca E, Marconi D, Bomben R, Gattei V, Lauria F, Gaidano G, Bertoni F.
    GENOME-WIDE DNA ANALYSIS IDENTIFIES RECURRENT IMBALANCES PREDICTING OUTCOME IN CHRONIC LYMPHOCYTIC LEUKAEMIA WITH 17p DELETION.
    Br J Haematol 143:532-536, 2008
  50. Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Zucchetto A, Bertoni F, Rossi FM, Bulian P, Cattarossi I, Ilariucci F, Sozzi E, Spina V, Zucca E, Degan M, Lauria F, Del Poeta G, Efremov DG, Marasca R, Gaidano G, Gattei V.
    MOLECULAR AND CLINICAL FEATURES OF CHRONIC LYMPHOCYTIC LEUKAEMIA WITH STEREOTYPED B CELL RECEPTORS: RESULTS FROM AN ITALIAN MULTICENTRIC STUDY.
    Br J Haematol 144:492-506, 2009
  51. Deambrogi C, Cresta S, Cerri M, Rasi S, De Paoli L, Ramponi A, Gaidano G, Rossi D.
    14q32 TRANSLOCATIONS AND RISK OF RICHTER’s TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKAEMIA.
    Br J Haematol 144:131-133, 2009
  52. Rossi D, Gaidano G.
    RICHTER SYNDROME: MOLECULAR INSIGHTS AND CLINICAL PERSPECTIVES.
    Hematol Oncol 27:1-10, 2009
  53. Rossi D, Cerri M, Deambrogi C, Sozzi E, Cresta S, Rasi S, De Paoli L, Spina V, Gattei V, Capello D, Forconi F, Lauria F, Gaidano G.
    THE PROGNOSTIC VALUE OF TP53 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA IS INDEPENDENT OF DEL17p13: IMPLICATIONS FOR OVERALL SURVIVAL AND CHEMOREFRACTORINESS.
    Clin Cancer Res 15:995-1004, 2009
  54. Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M, Deambrogi C, Ricca I, Rocci A, Ferrero S, Bernocco E, Capello D, De Paoli L, Bergui L, Boi M, Omedè P, Massaia M, Tarella C, Passera R, Boccadoro M, Gaidano G, Ladetto M.
    TELOMERE LENGTH IS AN INDEPENDENT PREDICTOR OF SURVIVAL, TREATMENT REQUIREMENT AND RICHTER’s SYNDROME TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Leukemia 23:1062-1072, 2009
  55. Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambo A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RDM, Snijders PJF, Meijer CJ, Pineau P, Dejean A, Llloveras B, Capella G, Quer J, Buti M, Esteban J-I, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D, Gaidano G, Cigudosa JC, Gomez-Lopez G, Pisano DG, Valencia A, Piris MA, Bosch FX, Cahir-McFarland E, Kieff E, Esteller M.
    THE DYNAMIC DNA METHYLOMES OF DOUBLE-STRANDED DNA VIRUSES ASSOCIATED WITH HUMAN CANCER.
    Genome Res 19:438-451, 2009
  56. Rossi D, Rasi S, Franceschetti S, Capello D, Castelli A, De Paoli L, Ramponi A, Chiappella A, Pogliani E, Vitolo U, Gaidano G.
    ANALYSIS OF THE HOST PHARMACOGENETIC BACKGROUND FOR PREDICTION OF OUTCOME AND TOXICITY IN DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP21.
    Leukemia 23:1118-1126, 2009
  57. Rossi D, Sala L, Minisini R, Fabris C, Falletti E, Cerri M, Burlone ME, Toniutto P, Gaidano G, Pirisi M.
    OCCULT HEPATITIS B VIRUS INFECTION OF PERIPHERAL BLOOD MONONUCLEAR CELLS AMONG TREATMENT-NAÏVE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
    Leukemia and Lymphoma 50:604-611, 2009
  58. Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PMV, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, Dalla-Favera R, Pasqualucci L, Bhagat G, Bertoni F.
    THE NF-kB NEGATIVE REGULATOR TNFAIP3 (A20) IS INACTIVATED BY SOMATIC MUTATIONS AND GENOMIC DELETIONS IN MARGINAL ZONE LYMPHOMAS.
    Blood 113:4918-4921, 2009
  59. Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V.
    CD38/CD31, THE CCL3 AND CCL4 CHEMOKINES, AND CD49d/VCAM-1 ARE INTERCHAINED BY SEQUENTIAL EVENTS SUSTAINING CHRONIC LYMPHOCYTIC LEUKEMIA SURVIVAL.
    Cancer Res 69:4001-4009, 2009 
  60. Capello D, Rasi S, Oreste P, Veronese S, Cerri M, Ravelli E, Rossi D, Minola E, Colosimo A, Gambacorta M, Muti G, Morra E, Gaidano G.
    MOLECULAR CHARACTERIZATION OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS OF DONOR ORIGIN OCCURRING IN LIVE TRANSPLANT RECIPIENTS.
    J Pathol 218:478-486, 2009
  61. Rossi F, Petrucci M, Guffanti A, Marcheselli L, Rossi D, Callea V, Federico V, De Muro M, Baraldi A, Villani O, Musto P, Bacigalupo A, Gaidano G, Avvisati G, Goldaniga M, De Paoli L, Baldini L.
    PROPOSAL AND VALIDATION OF PROGNOSTIC SCORING SYSTEMS FOR IgG AND IgA MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE.
    Clin Cancer Res 15:4439-4445, 2009
  62. Rossi D, Sozzi E, Puma A,  DE Paoli L, Rasi S, Spina V, Gozzetti A, Tassi M, C encini E, Raspadori D, Pinto V, Bertoni F, Gattei V, Lauria F, Gaidano G, Forconi F.
    THE PROGNOSIS OF CLINICAL MONOCLONAL B CELL LYMPHOCYTOSIS DIFFERS FROM PROGNOSIS OF RAI 0 CHRONIC LYMPHOCYTIC LEUKAEMIA AND IS RECAPITULATED BY BIOLOGICAL RISK FACTORS.
    Br J Haematol 146:64-75, 2009 
  63. Rossi D, Spina V, Cerri M, Rasi S, Deambrogi C, De Paoli L, Laurenti L, Maffei R, Forconi F, Bertoni F, Zucca E, Agostinelli C, Cabras A, Lucioni M, Martini M, Magni M, Deaglio S, Ladetto M, Nomdedeu J, Besson C, Ramponi A, Canzonieri V, Paulli M, Marasca R, Larocca LM, Carbone A, Pileri SA, Gattei V, Gaidano G.
    STEREOTYPED B-CELL RECEPTOR IS AN INDEPENDENT RISK FACTOR OF CHRONIC LYMPHOCYTIC LEUKEMIA TRANSFORMATION TO RICHTER SYNDROME.
    Clin Cancer Res 15:4415-4422, 2009
  64. Vitolo U, Chiappella A, Angelucci E, Rossi G, Liberati AM, Cabras MG, Botto B, Ciccone G, Gaidano G, Falchi L, Freilone R, Novero D, Orsucci L, Pavone L, Pogliani E, Rota-Scalabrini D, Salvi F, Tonso A, Tucci A, Levia A, on behalf of Gruppo Italiano Multiregionale Linfomi e Leucemie (GIMURELL).
    DOSE-DENSE AND HIGH DENSITY CHEMOTHERAPY PLUS RITUXIMAB WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR PRIMARY TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA AT POOR PROGNOSIS: A PHASE II MULTICENTER STUDY.
    Haematologica/The Hematology Journal 94:1250-1258, 2009  
  65. Toso A, Aluffi P, Capello D, Conconi A, Gaidano G, Pia F.
    CLINICAL AND MOLECULAR FEATURES OF MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMAS OF SALIVARY GLANDS.
    Head and Neck 31:1181-1187, 2009 
  66. Borie C, Colas C, Dartigues P, Lazure T, Rince P, Buhard O, Folliot P, Chalastanis A, Muleris M, Hamelin R, Mercier D, Oliveira C, Seruca R, Chadburn A, Leblond V, Barete S, Gaidano G, Martin A, Gaulard P, Fléjou J-F, Raphael M, Duval A.
    THE MECHANISMS UNDERLYING MMR DEFICIENCY IN IMMUNODEFICIENCY-RELATED NON HODGKIN LYMPHOMAS ARE DIFFERENT FROM THOSE IN OTHER SPORADIC MICROSATELLITE INSTABLE NEOPLASMS.
    Int J Cancer 125:2360-2366, 2009
  67. Lunghi M, Riccomagno P, De Paoli L, Vendramin C, Conconi A, Gaidano G, Rossi D.
    MONITORING OF CYTOMEGALOVIRUS REACTIVATION DURING INDUCTION AND NON-TRANSPLANT CONSOLIDATION OF ACUTE LEUKEMIA.
    Am J Hematol 84:697-698, 2009 (letter)
  68. Dal Bo M, Bertoni F, Forconi F, Zucchetto A, Bomben R, Marasca R, Deaglio S, Laurenti L, Efremov DG, Gaidano G, Del Poeta G, Gattei V.
    INTRINSIC AND EXTRINSIC FACTORS INFLUENCING THE CLINICAL COURSE OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: PROGNOSTIC MARKERS WITH PATHOGENETIC RELEVANCE.
    J Transl Med 7:76, 2009 
  69. Capello D, Scandurra M, Poretti G, Rancoita PMV, Mian M, Gloghini A, Deambrogi C, Martini M, Rossi D, Greiner TC, Chan WC, Ponzoni M, Montes Moreno S, Piris MA, Canzonieri V, Spina M, Tirelli U, Inghirami G, Rinaldi A, Zucca E, Dalla Favera R, Cavalli F, Larocca LM, Kwee I, Carbone A, Gaidano G, Bertoni F.
    GENOME WIDE DNA-PROFILING OF HIV-RELATED B-CELL LYMPHOMAS.
    Br J Haematol 148:245-255, 2010 
  70. Paulli M, Arcaini L, Lucioni M, Boveri E, Capello D, Passamonti F, Merli M, Rattotti S, Rossi D, Riboni R, Berti E, Magrini U, Bruno R, Gaidano G, Lazzarino M.
    SUBCUTANEOUS “LIPOMA-LIKE” B-CELL LYMPHOMA ASSOCIATED WITH HCV INFECTION: A NEW PRESENTATION OF PRIMARY EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF MALT.
    Ann Oncol 21:1189-1195, 2010 
  71. Rossi D, Fangazio M, De Paoli L, Puma A, Riccomagno P, Pinto V, Zigrossi P, Ramponi A, Monga G, Gaidano G.
    BETA-2-MICROGLOBULIN IS AN INDEPENDENT PREDICTOR OF PROGRESSION IN ASYMPTOMATIC MULTIPLE MYELOMA.
    Cancer 116:2188-2200, 2010 
  72. Lunghi M, Casorzo L, De Paoli L, Riccomagno P, Rossi D, Gaidano G.
    UNBALANCED t(1;16)(p11;p11.1) IN MYELODYSPLASTIC SYNDROMES: A CASE REPORT AND REVIEW OF THE LITERATURE.
    Cancer Genet Cytogenet 196:89-92, 2010 
  73. Rasi S, Forconi F, Bruscaggin A, Sozzi E, Gaidano G, Rossi D.
    IMPACT OF THE HOST GENETIC BACKGROUND ON PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA.
    Blood 115:1106-1197, 2010 (letter)  
  74. Scandurra M, Rossi D, Deambrogi C, Rancoita PMV, Chigrinova E, Mian M, Cerri M, Rasi S, Sozzi E, Forconi F, Ponzoni M, Montes Moreno S, Piris MA, Inghirami G, Zucca E, Gattei V, Rinaldi A, Kwee I, Gaidano G, Bertoni F.
    GENOMIC PROFILING OF RICHTER’s SYNDROME: RECURRENT LESIONS AND DIFFERENCES WITH DE NOVO DIFFUSE LARGE B CELL LYMPHOMAS.
    Hematol Oncol 28: 62-67, 2010 
  75. Bomben R, Dal Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM., Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei  V.
    EXPRESSION OF MUTATED IGHV3-23 GENES IN CHRONIC LYMPHOCYTIC LEUKEMIA IDENTIFIES A DISEASE SUBSET WITH PECULIAR CLINICAL AND BIOLOGICAL FEATURES.
    Clin Cancer Res 16:299-302, 2010
  76. Bomben R, Dal Bo M, Capello D, Forconi F, Bertoni F, Maffei R, Laurenti L, Rossi D, Zucca E, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.
    IGHD3-3 FAILS TO BEHAVE AS UNFAVOURABLE PROGNOSTIC MARKER IN CHRONIC LYMPHOCYTIC LEUKAEMIA.
    Br J Haematol 149:299-302, 2010 
  77. Palumbo A, Larocca A, Genuardi M, Kotwica K, Gay F, Rossi D, Benevolo G, Magarotto V, Cavallo F, Bringhen S, Rus C, Masini L, Iacobelli M, Gaidano G, Mitsiades C, Anderson K, Boccadoro M, Richardson P.
    MELPHALAN, PREDNISONE, THALIDOMIDE AND DEFIBROTIDE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: RESULTS OF MULTICENTER PHASE I/II TRIAL.
    Haematologica/The Hematology Journal 95:1144-1149, 2010 
  78. Rinaldi A, Capello D, Scandurra M, Greiner TC, Chan WC, Bhagat G, Rossi D, Morra E, Paulli M, Rambaldi A, Rancoita PM, Inghirami G, Ponzoni M, Montes Moreno S, Piris MA, Mian M, Chigrinova E, Zucca E, Dalla Favera R, Gaidano G, Kwee I, Bertoni F.
    SINGLE NUCLEOTIDE POLYMORPHISM-ARRAYS PROVIDE NEW INSIGHTS IN THE PATHOGENESIS OF POST-TRANSPLANT DIFFUSE LARGE B-CELL LYMPHOMA.
    Br J Haematol 149:569-577, 2010 
  79. Vaisitti T, Aydin S, Rossi D, Cottino F, Bergui L, D’Arena G, Bonello L, Horenstein AL, Brennan P, Pepper C, Gaidano G, Malavasi F, Deaglio S.
     INCREASES CXCL12-MEDIATED SIGNALS AND HOMING OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS.
    Leukemia 24:958-969, 2010 
  80. Bilous NI, Bomben R, Dal Bo M, Capello D, Forconi F, Laurenti L, Bertoni F, Efremov DG, Marasca R, Del Poeta G, Martina Z, Kryachouk I, Dyagil I, Gaidano G, Chumak A, Gattei V, Abramenko I.
    MOLECULAR AND CLINICAL FEATURES OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH STEREOTYPED B-CELL RECEPTORS IN A UKRAINIAN COHORT.
    Leuk Lymphoma 51:822-838, 2010
  81. Zucchetto A, Tripodo C, Benedetti D, Deaglio S, Gaidano G, Del Poeta G, Gattei V.
    MONOCYTES/MACROPHAGES BUT NOT T LYMPHOCYTES ARE THE MAJOR TARGETS OF THE CCL3/CCL4 CHEMOKINES PRODUCED BY CD38+/CD49d+ CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS.
    Br J Haematol 150:111-113, 2010 (letter) 
  82. Chigrinova E, Rinaldi A, Poretti G, Pruneri G, Neri A, Gaidano G, Ponzoni M, Zucca E, Bertoni F.
    NON-NEGATIVE MATRIX FACTORIZATION TO PERFORM UNSUPERVISED CLUSTERING OF GENOME WIDE DNA PROFILES IN MATURE B CELL LYMPHOID NEOPLASMS.
    Br J Haematol 150:229-232, 2010 (letter)
  83. Dal Bo M, Secchiero P, Degan M, Marconi D, Bomben R, Pozzato G, Gaidano G, Del Poeta G, Forconi F, Zauli G, Gattei V.
    MDM4/MDMX IS OVEREXPRESSED IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MARKS A SUBSET OF p53wild-type CLL WITH A POOR CYTOTOXIC RESPONSE TO NUTLIN-3.
    Br J Haematol 150:237-239, 2010 (letter)
  84. Rossi FM, Del Principe MI, Rossi D, Irno Consalvo M, Luciano F, Zucchetto A, Bulian P, Bomben R, Dal Bo M, Fangazio M, Benedetti D, Degan M, Gaidano G, Del Poeta G, Gattei V.
    PROGNOSTIC IMPACT OF ZAP-70 EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: MEAN FLUORESCENCE INTENSITY T/B RATIO VERSUS PERCENTAGE OF POSITIVE CELLS.
    J Transl Med 8:23, 2010 
  85. Pinto V, Castelli A, Gaidano G, Conconi A.
    SAFE AND EFFECTIVE USE OF PLERIXAFOR + G-CSF IN DIALYSIS-DEPENDENT RENAL FAILURE.
    Am J Hematol 85:461-462, 2010 (letter) 
  86. Maffei R, Martinelli S, Santachiara R, Rossi D, Guarnotta C, Sozzi E, Zucchetto A, Rigolin GM, Fiorcari S, Castelli I, Fontana M, Coluccio V, Leonardi G, Zucchini P, Tripodo C, Cuneo A, Gattei V, Del Poeta G, Forconi F, Gaidano G, Torelli G, Marasca R.
    ANGIOPOIETIN-2 PLASMA DOSAGE PREDICTS TIME TO FIRST TREATMENT AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Blood, 116:584-592, 2010 
  87. Amadori S, Suciu S, Selleslag D, Stasi R, Alimena G, Baila L, Rizzoli V, Borlenghi E, Gaidano G, Magro D, Torelli G, Muus P, Venditti A, Cacciola E, Lauria F, Vignetti M, de Witte T.
    RANDOMIZED TRIAL OF TWO SCHEDULES OF LOW-DOSE GEMTUZUMAB OZOGAMICIN AS INDUCTION MONOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA IN OLDER PATIENTS NOT CONSIDERED CANDIDATES FOR INTENSIVE CHEMOTHERAPY. A PHASE II STUDY OF THE EORTC AND GIMEMA LEUKAEMIA GROUPS (AML-19).
    Br J Haematol 149:376-382, 2010 
  88. Deambrogi C, De Paoli L, Fangazio M, Cresta S, Rasi S, Spina V, Gattei V, Gaidano G, Rossi D.
    ANALYSIS OF THE REL, BCL11A AND MYCN PROTO-ONCOGENES BELONGING TO THE 2p AMPLICON IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Am J Hematol 85:541-544, 2010
  89. Rossi D, Deambrogi C, Monti S, Cresta S, De Paoli L, Fangazio M, Bernasconi P, Gaidano G.
    BCL3 TRANSLOCATION IN CLL WITH TYPICAL PHENOTYPE: ASSESSMENT OF FREQUENCY, ASSOCIATION WITH CYTOGENETIC SUBGROUPS, AND PROGNOSTIC SIGNIFICANCE.
    Br J Haematol 150:702-704, 2010  
  90. Rossi D, Lobetti Bodoni C, Zucchetto A, Rasi S, De Paoli L, Fangazio M, Rossi FM, Ladetto M, Gattei V, Gaidano G.
    LOW CD49d AND LONG TELOMERE IDENTIFY A CHRONIC LYMPHOCYTIC LEUKEMIA SUBSET WITH HIGHLY FAVOURABLE OUTCOME.
    Am J Hematol 85:619-622, 2010  
  91. Scandurra M, Mian M, Greiner TC, De Campos CP, Chan WC, Vose JM, Chigrinova E, Inghirami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJM, Franceschetti S, Gaidano G, Montes-Moreno S, Piris MA, Facchetti F, Tucci A, Nomdedeu JF, Lazure T, Lambotte O, Uccella S, Pinotti G, Pruneri G, Martinelli G, Young KH, Tibiletti MG, Rinaldi A, Zucca E, Kwee I, Bertoni F.
    GENOMIC LESIONS ASSOCIATED WITH A DIFFERENT CLINICAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP-21.
    Br J Hematol 151:221-231, 2010
  92. Zibellini S, Capello D, Forconi F, Marcatili P, Rossi D, Franceschetti S, Sozzi E, Cencini E, Marasca R, Baldini L, Tucci A, Bertoni F, Passamonti F, Orlandi E, Varettoni M, Merli M, Rizzi S, Gattei V, Tramontano A, Paulli M, Gaidano G, Arcaini L.
    STEREOTYPED PATTERNS OF B-CELL RECEPTOR IN SPLENIC MARGINAL ZONE LYMPHOMA.
    Haematologica/The Hematology Journal 95:1792-1796, 2010  
  93. Rinaldi A, Forconi F, Arcaini L, Mian M, Sozzi E, Zibellini S, Baldini L, Franceschetti S, Gaidano G, Marasca R, Mollejo M, Piris MA, Tucci A, Facchetti F, Bhagat G, Dalla-Favera R, Rancoita PMV, Zucca E, Kwee I, Bertoni F.
    IMMUNOGENETIC FEATURES AND GENETIC LESIONS IN SPLENIC MARGINAL ZONE LYMPHOMA.
    Br J Hematol 151:435-9, 2010  
  94. Ponzoni M, Uccella S, Mian M, Rinaldi A, Facchetti F, Pruneri G, Gaidano G, Capella C, Zucca E, Doglioni C, Bertoni F.
    SYK EXPRESSION PATTERNS DIFFER AMONG B-CELL LYMPHOMAS.
    Leuk Res 34:e243-e245, 2010 
  95. Bringhen S, Larocca A, Rossi D, Cavalli M, Genuardi M, Ria R, Gentili S, Patriarca F, Nozzoli C, Levi A, Guglielmelli T, Benevolo G, Callea V, Rizzo V, Cangialosi C, Musto P, De Rosa L, Liberati AM, Grasso M, Falcone AP, Evangelista A, Cavo M, Gaidano G, Boccadoro M, Palumbo A.
    EFFICACY AND SAFETY OF ONCE WEEKLY BORTEZOMIB IN MULTIPLE MYELOMA PATIENTS.
    Blood 116:4745-4753, 2010
  96. Crowther-Swanepoel D, Corre T, Lloyd A, Gaidano G, OlverB,Bennett FL, DoughtyC,TonioloD, Calligaris-CappioF, Ghia P, RossiD,RawstronAC, Catovsky D, Houlston RS.
    INHERITED GENETIC SUSCEPTIBILITY TO MONOCLONAL B-CELL LYMPHOCYTOSIS.
    Blood 116:5957-5960, 2010 
  97. Rasi S, Spina V, Bruscaggin A, Vaisitti T, Tripodo C, Forconi F, De Paoli L, Fangazio M, Sozzi E, Cencini E, Laurenti L, Marasca R, Visco C, Xu-Monette ZY, Gattei V, Young KH, Malavasi F, Deaglio S, Gaidano G, RossiD.
    A VARIANT OF THE LRP4 GENE AFFECTS THE RISK OF CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION TO RICHTER SYNDROME.
    Br J Haematol 152:284-294, 2010
  98. Stratta P, Airoldi A, Izzo C, Rossi D, Gaidano G.
    FREE LIGHT-CHAINS AND RENAL DISORDERS: WHEN SMALL IS WORSE. Lancet 376:1221, 2010 (letter)  
  99. Rossi D, Gaidano G.
    BIOLOGICAL AND CLINICAL SIGNIFICANCE OF STEREOTYPED B CELL RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Haematologica 95:1992-1995, 2010 (Editorial)  
  100. Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U, Rancoita PMV, De Campos CP, Forconi F, Gascoyne RD, Facchetti F, Ponzoni M, Govi S, Ferreri AJM, Mollejo M, Piris MA, Baldini L, Soulier J, Thieblemont C, Canzonieri V, Gattei V, Marasca R, Franceschetti S, Gaidano G, Tucci A, Uccella S, Tibiletti MG, Dirnhofer S, Tripodo C, Doglioni C, Dalla-Favera R, Cavalli F, Zucca E, Kwee I, Bertoni F.
    GENOME WIDE-DNA-PROFILING OF MARGINAL ZONE LYMPHOMAS IDENTIFIES SUBTYPE-SPECIFIC LESIONS WITH AN IMPACT ON THE CLINICAL OUTCOME.
    Blood 117:1595-604, 2011 
  101. Chigrinova E, Mian M, Scandurra M, Greiner TC, Chan WC, Vose JM, Inghrami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJM, Franceschetti S, Gaidano G, Tucci A, Facchetti F, Lazure T, Lambotte O, Montes-Moreno S, Piris MA, Nomdedeu JFr, Uccella S, Rancoita PMV, Kwee I, Zucca E, Bertoni F.
    DIFFUSE LARGE B-CELL LYMPHOMA WITH CONCORDANT BONE MARROW INVOLVEMENT HAS PECULIAR GENOMIC PROFILE AND POOR CLINICAL OUTCOME.
    Hematol Oncol 29:38-41, 2011 
  102. Stratta P, Gravellone L, Cena T, Rossi D, Gaidano G, Fenoglio R, Lazzarich E, Quaglia M, Airoldi A, Bozzola C, Monga G, Valente G, Canavese C, Magnani C.
    RENAL OUTCOME AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE IN 289 OLD PATIENTS WITH BLOOD CELL DYSCRASIAS: A SINGLE CENTER EXPERIENCE.
    Crit Rev Oncol Hematol 79:31-42, 2011  
  103. Bulian P, Tarnani M, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, Deaglio S, D’Arena G, Efremov D, Marasca R, Lauria F, Gattei V, Gaidano G, Laurenti L.
    MULTICENTER VALIDATION OF A PROGNOSTIC INDEX FOR OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Hematol Oncol 29:91-9, 2011  
  104. Ferretti E, Bertolotto M, Deaglio S, Tripodo C, Ribatti D, Audrito V, Blengio F, Matis S, Zupo S, Rossi D, Ottonello L, Gaidano G, Malavasi F, Pistoia V, Corcione A.
    A NOVEL ROLE OF THE CX3CR1/CX3CL1 SYSTEM IN THE CROSS-TALK BETWEEN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS AND TUMOR MICROENVIRONMENT.
    Leukemia 25:1268-77, 2011 
  105. Mian M, Rinaldi A, Mensah AA, Rossi D, Ladetto M, Forconi F, Marasca R, Gattei V, Zucca E, Cavalli F, Gaidano G, Kwee I, Bertoni F.
    DEL(13q14) LENGTH MATTERS: AN INTEGRATED ANALYSIS OF GENOMIC, FISH AND CLINICAL DATA IN 169 CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH 13q DELETION ALONE OR NORMAL KARYOTYPE.
    Hematol Oncol 30:46-9, 2011 (letter) 
  106. Wade R, Di Bernardo MC, Richards S, Rossi D, Crowther-Swanepoel D, Gaidano G, Oscier DG, Catovsky D, Houlston RS.
    ASSOCIATION BETWEEN SNP-GENOTYPE AND CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOME IN A RANDOMIZED CHEMOTHERAPY TRIAL.
    Haematologica/The Hematology Journal 96:1496-503, 2011 
  107. Rossi D, Deaglio S, Dominguez-Sola D, Rasi S, Vaisitti T, Agostinelli C, Spina V, Bruscaggin A, Monti S, Cerri M, Cresta S, Fangazio M, Arcaini L, Lucioni M, Marasca R, Thieblemont C, Capello D, Facchetti F, Kwee I, Pileri SA, Foà R, Bertoni F, Dalla-Favera R, Pasqualucci L, Gaidano G.
    ALTERATIONS OF BIRC3 AND MULTIPLE OTHER NF-?B PATHWAY GENES IN SPLENIC MARGINAL ZONE LYMPHOMA.
    Blood 118(18):4930-4, 2011 
  108. Testoni M, Kwee I, Greiner TC, Montes-Moreno S, Vose J, Chan WC, Chiappella A, Baldini L, Ferreri AJ, Gaidano G, Mian M, Zucca E, Bertoni F.
    Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Br J Haematol 155(2):274-7, 2011  
  109. Kwee I, Rancoita PM, Rinaldi A, Ferreri AJ, Bhagat G, Gascoyne RD, Canzonieri V, Gaidano G, Doglioni C, Zucca E, Ponzoni M, Bertoni F.
    Genomic profiles of MALT lymphomas: variability across anatomical sites.
    Haematologica 96(7):1064-6, 2011  
  110. Chigrinova E, Mian M, Shen Y, Greiner TC, Chan WC, Vose JM, Inghirami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJ, Franceschetti S, Gaidano G, Tucci A, Facchetti F, Lazure T, Lambotte O, Montes-Moreno S, Piris MA, Zucca E, Kwee I, Bertoni F.
    Integrated profiling of diffuse large B-cell lymphoma with 7q gain. Br J Haematol 153(4):499-503, 2011  
  111. Fangazio M, De Paoli L, Rossi D, Gaidano G.
    Predictive markers and driving factors behind Richter syndrome development.
    Expert Rev Anticancer Ther 11(3):433-42, 2011  
  112. Rinaldi A, Ponzoni M, Uccella S, Rossi D, Gaidano G, Facchetti F, Pruneri G, Tibiletti MG, Capella C, Zucca E, Doglioni C, Catapano C, Bertoni F.
    In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.
    Hematol Oncol 29(3):164-6, 2011.  
  113. Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R.
    Inactivating mutations of acetyltransferase genes in B-cell lymphoma.
    Nature 471(7337):189-95, 2011.  
  114. Mian M, Gaidano G, Conconi A, Tsang R, Gospodarowicz MK, Rambaldi A, Rossi A, Oldani E, Federico M, Luminari S, Bellei M, Pogliani EM, Rossini F, Cabrera ME, Martelli M, Lopez-Guillermo A, Busetto M, Cavalli F, Zucca E, Cortelazzo S.
    High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study.
                 Leuk Lymphoma 52(5):823-32, 2011  
  115. Dal-Bo M, Del Giudice I, Bomben R, Capello D, Bertoni F, Forconi F, Laurenti L, Rossi D, Zucchetto A, Pozzato G, Marasca R, Efremov DG, Guarini A, Del Poeta G, Foà R, Gaidano G, Gattei V.
    B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.
    Br J Haematol 153(1):3-14, 2011  
  116. Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K, Arcaini L, Lucioni M, Rocque GB, Xu-Monette ZY, Visco C, Chang J, Chigrinova E, Forconi F, Marasca R, Besson C, Papadaki T, Paulli M, Larocca LM, Pileri SA, Gattei V, Bertoni F, Foà R, Young KH, Gaidano G.
    The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation.
    Blood 117(12):3391-401, 2011  
  117. Rossi D, Gaidano G.
    TRACKING THE BIOLOGICAL RISK OF CORONARY ARTERY DISEASE IN HIV-INFECTED INDIVIDUALS: THE CASE OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS.
    AIDS 25(3):379-81, 2011  
  118. Saborit-Villarroya I, Vaisitti T, Rossi D, D'Arena G, Gaidano G, Malavasi F, Deaglio S.
    E2A IS A TRANSCRIPTIONAL REGULATOR OF CD38 EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Leukemia 25:479-88, 2011  
  119. Ripellino P, Comi C, Mula M, Varrasi C, Conconi A, Stecco A, Brustia D, Nasuelli N, Savio K, De Paoli L, Cantello R, Gaidano G, Monaco F.
    PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION: A TREATMENT OPTION.
    BMJ Case Rep 2011 Apr 15;2011. pii: bcr1120103549.  
  120. Rossi D, Rasi S, Di Rocco A, Fabbri A, Forconi F, Gloghini A, Bruscaggin A, Franceschetti S, Fangazio M, De Paoli L, Bruna R, Capello D, Chiappella A, Lobetti Bodoni C, Giachelia M, Tisi MC, Pogliani EM, Lauria F, Ladetto M, Hohaus S, Martelli M, Vitolo U, Carbone A, Foà R, Gaidano G.
    THE HOST GENETIC BACKGROUND OF DNA REPAIR MECHANISMS IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA.
    Blood 117(8):2405-13, 2011  
  121. Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Foà R.
    THE COEXISTENCE OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MYELOPROLIPERATIVE NEOPLASMS: A RETROSPECTIVE MULTICENTRIC GIMEMA EXPERIENCE.
    Am J Hematol 86(12):1007-12, 2011  
  122. Elia L, Grammatico S, Paoloni F, Vignetti M, Rago A, Cenfra N, Mecarocci S, Mancini M, Luciani M, Di Raimondo F, Cazzaniga G, Matarazzo M, Moleti ML, Santoro L, Gaidano G, Foà R, Mandelli F, Cimino G.
    CLINICAL OUTCOME AND MONITORING OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA EXPRESSING THE MLL/ENL FUSION GENE.
    Am J Hematol 86(12):993-7, 2011  
  123. Rossi D, Deaglio S, Dominguez-Sola D, Rasi S, Vaisitti T, Agostinelli C, Spina V, Bruscaggin A, Monti S, Cerri M, Cresta S, Fangazio M, Arcaini L, Lucioni M, Marasca R, Thieblemont C, Capello D, Facchetti F, Kwee I, Pileri SA, Foà R, Bertoni F, Dalla-Favera R, Pasqualucci L, Gaidano G.
    ALTERATION OF BIRC3 AND MULTIPLE OTHER NF-?B PATHWAY GENES IN SPLENIC MARGINAL ZONE LYMPHOMA.
    Blood 118(18):4930-4, 2011  
  124. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R.
    ANALYSIS OF THE CODING GENOME OF DIFFUSE LARGE B-CELL LYMPHOMA.
    Nat Genet 43(9):830-7, 2011  
  125. Pession A, Masetti R, Gaidano G, Tosi P, Rosti G, Aglietta M, Specchia G, Porta F, Pane F.
    RISK EVALUATION, PROPHYLAXIS, AND TREATMENT OF TUMOR LYSIS SYNDROME: CONSENSUS OF AN ITALIAN EXPERT PANEL.
    Adv Ther 28(8):684-97, 2011  
  126. Rinaldi A, Mian M, Kwee I, Rossi D, Deambrogi C, Mensah AA, Forconi F, Spina V, Cencini E, Drandi D, Ladetto M, Santachiara R, Marasca R, Gattei V, Cavalli F, Zucca E, Gaidano G, Bertoni F.
    GENOME-WIDE DNA PROFILING BETTER DEFINES THE PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKAEMIA.
    Br J Haematol 154(5):590-9, 2011  
  127. Falco P, Levis A, Stacchini A, Ciriello MM, Geuna M, Notari P, Omedè P, Pautasso M, Prato G, Strola G, Gioia D, Bonferroni M, Cametti G, Ferrero D, Freilone R, Gaidano G, Marinone C, Marmont F, Pollio B, Salvi F, Saglio G, Girotto M; Piedmont MDS Registry--Italy.
    PROGNOSTIC RELEVANCE OF CYTOMETRIC QUANTITATIVE ASSESSMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.
    Eur J Haematol 87(5):409-18, 2011  
  128. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Foá R, Pasqualucci L, Rabadan R, Dalla-Favera R, Gaidano G.
    ANALYSIS OF THE CHRONIC LYMPHOCYTIC LEUKEMIA CODING GENOME: ROLE OF NOTCH1 MUTATIONAL ACTIVATION.
    J Exp Med 208(7):1389-401, 2011  
  129. Rasi S, Bruscaggin A, Rinaldi A, Cresta S, Fangazio M, De Paoli L, Monti S, Gargiulo E, Kwee I, Foà R, Bertoni F, Gaidano G, Rossi D.
    SALIVA IS A RELIABLE AND PRACTICAL SOURCE OF GERMLINE DNA FOR GENOME-WIDE STUDIES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Leuk Res 35(10):1419-22, 2011  
  130. Wade R, Di Bernardo MC, Richards S, Rossi D, Crowther-Swanepoel D, Gaidano G, Oscier DG, Catovsky D, Houlston RS.
    ASSOCIATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISM-GENOTYPE AND OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN A RANDOMIZED CHEMOTHERAPY TRIAL.
    Haematologica 96(10):1496-503, 2011  
  131. Audrito V, Vaisitti T, Rossi D, Gottardi D, D'Arena G, Laurenti L, Gaidano G, Malavasi F, Deaglio S.
    NICOTINAMIDE BLOCKS PROLIFERATION AND INDUCES APOPTOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS THROUGH ACTIVATION OF THE P53/MIR-34A/SIRT1 TUMOR SUPPRESSOR NETWORK.
    Cancer Res 71(13):4473-83, 2011  
  132. Dal Bo M, Rossi FM, Rossi D, Deambrogi C, Bertoni F, Del Giudice I, Palumbo G, Nanni M, Rinaldi A, Kwee I, Tissino E, Corradini G, Gozzetti A, Cencini E, Ladetto M, Coletta AM, Luciano F, Bulian P, Pozzato G, Laurenti L, Forconi F, Di Raimondo F, Marasca R, Del Poeta G, Gaidano G, Foà R, Guarini A, Gattei V.
    13q14 DELETION SIZE AND NUMBER OF DELETED CELLS BOTH INFLUENCE PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Genes Chrom Cancer 50(8):633-43, 2011  
  133. Crowther-Swanepoel D, Di Bernardo MC, Jamroziak K, Karabon L, Frydecka I, Deaglio S, D'Arena G, Rossi D, Gaidano G, Olver B, Lloyd A, Broderick P, Laurenti L, Szemraj-Rogucka Z, Robak T, Catovsky D, Houlston RS.
    COMMON GENETIC VARIATION AT 15Q25.2 IMPACTS ON CHRONIC LYMPHOCYTIC LEUKAEMIA RISK.
    Br J Haematol 154(2):229-33, 2011  
  134. Ferretti E, Bertolotto M, Deaglio S, Tripodo C, Ribatti D, Audrito V, Blengio F, Matis S, Zupo S, Rossi D, Ottonello L, Gaidano G, Malavasi F, Pistoia V, Corcione A.
    A NOVEL ROLE OF THE CX3CR1/CX3CL1 SYSTEM IN THE CROSS-TALK BETWEEN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND TUMOR MICROENVIRONMENT.
    Leukemia 25(8):1268-77, 2011  
  135. Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M, Fangazio M, Vaisitti T, Monti S, Chiaretti S, Guarini A, Del Giudice I, Cerri M, Cresta S, Deambrogi C, Gargiulo E, Gattei V, Forconi F, Bertoni F, Deaglio S, Rabadan R, Pasqualucci L, Foà R, Dalla-Favera R, Gaidano G.
    MUTATIONS OF THE SF3B1 SPLICING FACTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA: ASSOCIATION WITH PROGRESSION AND FLUDARABINE-REFRACTORINESS.
    Blood 118(26):6904-8, 2011  
  136. Serra S, Horenstein AL, Vaisitti T, Brusa D, Rossi D, Laurenti L, D'Arena G, Coscia M, Tripodo C, Inghirami G, Robson SC, Gaidano G, Malavasi F, Deaglio S.
    CD73-GENERATED EXTRACELLULAR ADENOSINE IN CHRONIC LYMPHOCYTIC LEUKEMIA CREATES LOCAL CONDITIONS COUNTERACTING DRUG-INDUCED CELL DEATH.
    Blood 118(23):6141-52, 2011  
  137. Rossi D, Rasi S, Spina V, Fangazio M, Monti S, Greco M, Ciardullo C, Famà R, Cresta S, Bruscaggin A, Laurenti L, Martini M, Musto P, Forconi F, Marasca R, Larocca LM, Foà R, Gaidano G.
    DIFFERENT IMPACT OF NOTCH1 AND SF3B1 MUTATIONS ON THE RISK OF CHRONIC LYMPHOCYTIC LEUKEMIA TRANSFORMATION TO RICHTER SYNDROME.
    Br J Haematol 158(3):426-9, 2012  
  138. Rasi S, Monti S, Spina V, Foà R, Gaidano G, Rossi D.
    ANALYSIS OF NOTCH1 MUTATIONS IN MONOCLONAL B-CELL LYMPHOCYTOSIS.
    Haematologica 97(1):153-4, 2012  
  139. Rossi D, Spina V, Forconi F, Capello D, Fangazio M, Rasi S, Martini M, Gattei V, Ramponi A, Larocca LM, Bertoni F, Gaidano G.
    MOLECULAR HISTORY OF RICHTER SYNDROME: ORIGIN FROM A CELL ALREADY PRESENT AT THE TIME OF CHRONIC LYMPHOCYTIC LEUKEMIA DIAGNOSIS.
    Int J Cancer 130(12):3006-10, 2012  
  140. Kwee I, Capello D, Rinaldi A, Rancoita PM, Bhagat G, Greiner TC, Spina M, Gloghini A, Chan WC, Paulli M, Zucca E, Tirelli U, Carbone A, Gaidano G, Bertoni F.
    GENOMIC ABERRATIONS AFFECTING THE OUTCOME OF IMMUNODEFICIENCY-RELATED DIFFUSE LARGE B-CELL LYMPHOMA.
    Leuk Lymphoma 53(1):71-6, 2012  
  141. Maurillo L, Venditti A, Spagnoli A, Gaidano G, Ferrero D, Oliva E, Lunghi M, D'Arco AM, Levis A, Pastore D, Di Renzo N, Santagostino A, Pavone V, Buccisano F, Musto P.
    AZACITIDINE FOR THE TREATMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA: REPORT OF 82 PATIENTS ENROLLED IN AN ITALIAN COMPASSIONATE PROGRAM.
    Cancer 118(4):1014-22, 2012  
  142. Mian M, Scandurra M, Chigrinova E, Shen Y, Inghirami G, Greiner TC, Chan WC, Vose JM, Testoni M, Chiappella A, Baldini L, Ponzoni M, Ferreri AJ, Franceschetti S, Gaidano G, Montes-Moreno S, Piris MA, Facchetti F, Tucci A, Nomdedeu JF, Lazure T, Uccella S, Tibiletti MG, Zucca E, Kwee I, Bertoni F.
    CLINICAL AND MOLECULAR CHARACTERIZATION OF DIFFUSE LARGE B-CELL LYMPHOMAS WITH 13Q14.3 DELETION.
    Ann Oncol 23(3):729-35, 2012  
  143. Mian M, Rinaldi A, Mensah AA, Rossi D, Ladetto M, Forconi F, Marasca R, Gattei V, Zucca E, Cavalli F, Gaidano G, Kwee I, Bertoni F.
    DEL(13q14.3) LENGTH MATTERS: AN INTEGRATED ANALYSIS OF GENOMIC, FLUORESCENCE IN SITU HYBRIDIZATION AND CLINICAL DATA IN 169 CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS WITH 13Q DELETION ALONE OR A NORMAL KARYOTYPE.
    Hematol Oncol 30(1):46-9, 2012  
  144. Rigacci L, Puccini B, Cortelazzo S, Gaidano G, Piccin A, D'Arco A, Freilone R, Storti S, Orciuolo E, Zinzani PL, Zaja F, Bongarzoni V, Balzarotti M, Rota-Scalabrini D, Patti C, Gobbi M, Carpaneto A, Liberati AM, Bosi A, Iannitto E.
    BENDAMUSTINE WITH OR WITHOUT RITUXIMAB FOR THE TREATMENT OF HEAVILY PRETREATED NON-HODGKIN'S LYMPHOMA PATIENTS : A MULTICENTER RETROSPECTIVE STUDY ON BEHALF OF THE ITALIAN LYMPHOMA FOUNDATION (FIL).
    Ann Hematol 91(7):1013-22, 2012  
  145. Bomben R, Gobessi S, Dal Bo M, Volinia S, Marconi D, Tissino E, Benedetti D, Zucchetto A, Rossi D, Gaidano G, Del Poeta G, Laurenti L, Efremov DG, Gattei V.
    THE MIR-17~92 FAMILY REGULATES THE RESPONSE TO TOLL-LIKE RECEPTOR 9 TRIGGERING OF CLL CELLS WITH UNMUTATED IGHV GENES.
    Leukemia 26(7):1584-93, 2012  
  146. Rossi D, Fangazio M, Rasi S, Vaisitti T, Monti S, Cresta S, Chiaretti S, Del Giudice I, Fabbri G, Bruscaggin A, Spina V, Deambrogi C, Marinelli M, Famà R, Greco M, Daniele G, Forconi F, Gattei V, Bertoni F, Deaglio S, Pasqualucci L, Guarini A, Dalla-Favera R, Foà R, Gaidano G.
    DISRUPTION OF BIRC3 ASSOCIATES WITH FLUDARABINE CHEMOREFRACTORINESS IN TP53 WILD-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA.
    Blood 119(12):2854-62, 2012  
  147. Zucchetto A, Vaisitti T, Benedetti D, Tissino E, Bertagnolo V, Rossi D, Bomben R, Dal Bo M, Del Principe MI, Gorgone A, Pozzato G, Gaidano G, Del Poeta G, Malavasi F, Deaglio S, Gattei V.
    THE CD49D/CD29 COMPLEX IS PHYSICALLY AND FUNCTIONALLY ASSOCIATED WITH CD38 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA CELLS.
    Leukemia 26(6):1301-12, 2012  
  148. Bulian P, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, D'Arena G, Efremov DG, Marasca R, Lauria F, Gaidano G, Gattei V, Laurenti L.
    IGHV GENE MUTATIONAL STATUS AND 17P DELETION ARE INDEPENDENT MOLECULAR PREDICTORS IN A COMPREHENSIVE CLINICAL-BIOLOGICAL PROGNOSTIC MODEL FOR OVERALL SURVIVAL PREDICTION IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    J Transl Med Jan 30;10:18, 2012  
  149. Forconi F, Potter KN, Sozzi E, Henderson I, Cencini E, Rossi D, Bomben R, Gattei V, Gaidano G, Packham G, Stevenson FK.
    THE IGHV1-69/IGHJ3 RECOMBINATIONS OF UNMUTATED CLL ARE DISTINCT FROM THOSE OF NORMAL B CELLS.
    Blood 119(9):2106-9, 2012  
  150. Rossi D, Gaidano G.
    ATM AND CHRONIC LYMPHOCYTIC LEUKEMIA: MUTATIONS, AND NOT ONLY DELETIONS, MATTER.
    Haematologica 97(1):5-8, 2012  
  151. Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S, Laurenti L, Marasca R, Rasi S, Fangazio M, Guarini A, Gaidano G, Foà R.
    NOTCH1 MUTATIONS IN +12 CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CONFER AN UNFAVORABLE PROGNOSIS, INDUCE A DISTINCTIVE TRANSCRIPTIONAL PROFILING AND REFINE THE INTERMEDIATE PROGNOSIS OF +12 CLL.
    Haematologica 97(3):437-41, 2012  
  152. Ferrero S, Capello D, Svaldi M, Boi M, Gatti D, Drandi D, Rossi D, Barbiero S, Mantoan B, Mantella E, Zanni M, Ghione P, Larocca A, Passera R, Bertoni F, Gattei V, Forconi F, Laurenti L, Del Poeta G, Marasca R, Cortelazzo S, Gaidano G, Palumbo A, Boccadoro M, Ladetto M.
    MULTIPLE MYELOMA SHOWS NO INTRA-DISEASE CLUSTERING OF IMMUNOGLOBULIN HEAVY CHAIN GENES.
    Haematologica 97(6):849-53, 2012  
  153. Mensah AA, Rinaldi A, Ponzoni M, Canzonieri V, Uccella S, Rossi D, Bhagat G, Gaidano G, Zucca E, Bertoni F.
    ABSENCE OF NOTCH1 GENE MUTATIONS IN MALT LYMPHOMAS.
    Br J Haematol 157(3):382-4, 2012  
  154. Kwee I, Rinaldi A, Rancoita P, Rossi D, Capello D, Forconi F, Giuliani N, Piva R, Inghirami G, Gaidano G, Zucca E, Bertoni F.
    INTEGRATED DNA COPY NUMBER AND METHYLATION PROFILING OF LYMPHOID NEOPLASMS USING A SINGLE ARRAY.
    Br J Haematol 156(3):354-7, 2012  
  155. Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, Marasca R, Laurenti L, Bruscaggin A, Cerri M, Monti S, Cresta S, Famà R, De Paoli L, Bulian P, Gattei V, Guarini A, Deaglio S, Capello D, Rabadan R, Pasqualucci L, Dalla-Favera R, Foà R, Gaidano G.
    MUTATIONS OF NOTCH1 ARE AN INDEPENDENT PREDICTOR OF SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Blood 119(2):521-9, 2012  
  156. Pinato DJ, Rossi D, Minh MT, Toniutto P, Boccato E, Minisini R, Gaidano G, Pirisi M.
    HEPATITIS B VIRUS AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP.
    Dig Liver Dis 44(3):235-8, 2012  
  157. Rossi D, Gaidano G.
    MOLECULAR GENETICS OF HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA.
    Expert Rev Hematol 5(6):593-602, 2012  
  158. Rossi D, Fangazio M, Gaidano G.
    THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Mediterr J Hematol Infect Dis 4(1):e2012076, 2012  
  159. Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Ciardullo C, Deambrogi C, Khiabanian H, Serra R, Bertoni F, Forconi F, Laurenti L, Marasca R, Dal-Bo M, Rossi FM, Bulian P, Nomdedeu J, Del Poeta G, Gattei V, Pasqualucci L, Rabadan R, Foà R, Dalla-Favera R, Gaidano G.
    INTEGRATED MUTATIONAL AND CYTOGENETIC ANALYSIS IDENTIFIES NEW PROGNOSTIC SUBGROUPS IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Blood 121(8):1403-12, 2013  
  160. Del Poeta G, Dal Bo M, Del Principe MI, Pozzo F, Rossi FM, Zucchetto A, Bomben R, Degan M, Rasi S, Rossi D, Bulian P, Gaidano G, Amadori S, Gattei V.
    CLINICAL SIGNIFICANCE OF C.7544-7545 DELCT NOTCH1 MUTATION IN CHRONIC LYMPHOCYTIC LEUKAEMIA.
    Br J Haematol 160(3):415-8, 2013  
  161. Capello D, Gloghini A, Baldanzi G, Martini M, Deambrogi C, Lucioni M, Piranda D, Famà R, Graziani A, Spina M, Tirelli U, Paulli M, Larocca LM, Gaidano G, Carbone A, Sinigaglia F.
    ALTERATIONS OF NEGATIVE REGULATORS OF CYTOKINE SIGNALLING IN IMMUNODEFICIENCY-RELATED NON-HODGKIN LYMPHOMA.
    Hematol Oncol 31(1):22-8, 2013  
  162. Greco M, Capello D, Bruscaggin A, Spina V, Rasi S, Monti S, Ciardullo C, Cresta S, Fangazio M, Gaidano G, Foà R, Rossi D.
    ANALYSIS OF SF3B1 MUTATIONS IN MONOCLONAL B-CELL LYMPHOCYTOSIS.
    Hematol Oncol 31(1):54-5, 2013  
  163. Breccia M, Fianchi L, Lunghi M, Gaidano G, Levis A, Finelli C, Santini V, Musto P, Mansueto G, Oliva EN, Leoni P, Spiriti MA, Hohaus S, Leone G, Alimena G, Voso MT.
    NEWLY PROPOSED THERAPY-RELATED MYELODYSPLASTIC SYNDROME PROGNOSTIC SCORE PREDICTS SIGNIFICANT DIFFERENCES IN OVERALL SURVIVAL AND LEUKEMIA-FREE SURVIVAL IN PATIENTS TREATED WITH AZACITIDINE.
    Leuk Lymphoma 54(8):1786-7, 2013  
  164. De Paoli L, Cerri M, Monti S, Rasi S, Spina V, Bruscaggin A, Greco M, Ciardullo C, Famà R, Cresta S, Maffei R, Ladetto M, Martini M, Laurenti L, Forconi F, Marasca R, Larocca LM, Bertoni F, Gaidano G, Rossi D.
    MGA, A SUPPRESSOR OF MYC, IS RECURRENTLY INACTIVATED IN HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA.
    Leuk Lymphoma 54(5):1087-90, 2013  
  165. Marasca R, Maffei R, Martinelli S, Fiorcari S, Bulgarelli J, Debbia G, Rossi D, Rossi FM, Rigolin GM, Martinelli S, Gattei V, Del Poeta G, Laurenti L, Forconi F, Montillo M, Gaidano G, Luppi M.
    CLINICAL HETEROGENEITY OF DE NOVO 11Q DELETION CHRONIC LYMPHOCYTIC LEUKAEMIA: PROGNOSTIC RELEVANCE OF EXTENT OF 11Q DELETED NUCLEI INSIDE LEUKEMIC CLONE.
    Hematol Oncol 31(2):348-55, 2013  
  166. Gaidano G, Foà R, Dalla-Favera R.
    MOLECULAR PATHOGENESIS OF CHRONIC LYMPHOCYTIC LEUKEMIA.
    J Clin Invest 122(10):3432-8, 2012  
  167. Falco P, Cavallo F, Larocca A, Rossi D, Guglielmelli T, Rocci A, Grasso M, Siez ML, De Paoli L, Oliva S, Molica S, Mina R, Gay F, Benevolo G, Musto P, Omedè P, Freilone R, Bringhen S, Carella AM, Gaidano G, Boccadoro M, Palumbo A.
    LENALIDOMIDE-PREDNISONE INDUCTION FOLLOWED BY LENALIDOMIDE-MELPHALAN-PREDNISONE CONSOLIDATION AND LENALIDOMIDE-PREDNISONE MAINTENANCE IN NEWLY DIAGNOSED ELDERLY UNFIT MYELOMA PATIENTS.
    Leukemia 27(3):695-701, 2013  
  168. Vaisitti T, Serra S, Pepper C, Rossi D, Laurenti L, Gaidano G, Malavasi F, Deaglio S.
    CD38 SIGNALS UPREGULATE EXPRESSION AND FUNCTIONS OF MATRIX METALLOPROTEINASE-9 IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS.
    Leukemia 27(5):1177-81, 2013  
  169. Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C, Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A, Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabbò F, Serra R, Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R, Facchetti F, Arcaini L, Inghirami G, Bertoni F, Pileri SA, Deaglio S, Foà R, Dalla-Favera R, Pasqualucci L, Rabadan R, Gaidano G.
    THE CODING GENOME OF SPLENIC MARGINAL ZONE LYMPHOMA: ACTIVATION OF NOTCH2 AND OTHER PATHWAYS REGULATING MARGINAL ZONE DEVELOPMENT.
    J Exp Med 209(9):1537-51, 2012  
  170. Fianchi L, Criscuolo M, Lunghi M, Gaidano G, Breccia M, Levis A, Finelli C, Santini V, Musto P, Oliva EN, Leoni P, Aloe Spiriti A, D'Alò F, Hohaus S, Pagano L, Leone G, Voso MT.
    OUTCOME OF THERAPY-RELATED MYELOID NEOPLASMS TREATED WITH AZACITIDINE.
    J Hematol Oncol 5:44, 2012  
  171. Oliva EN, Finelli C, Santini V, Poloni A, Liso V, Cilloni D, Impera S, Terenzi A, Levis A, Cortelezzi A, Ghio R, Musto P, Semenzato G, Clissa C, Lunghi T, Trappolini S, Gaidano V, Salvi F, Reda G, Villani O, Binotto G, Cufari P, Cavalieri E, Spiriti MA.
    QUALITY OF LIFE AND PHYSICIANS' PERCEPTION IN MYELODYSPLASTIC SYNDROMES.
    Am J Blood Res 2(2):136-47, 2012  
  172. Carella AM, de Souza CA, Luminari S, Marcheselli L, Chiappella A, di Rocco A, Cesaretti M, Rossi A, Rigacci L, Gaidano G, Merli F, Spina M, Stelitano C, Hohaus S, Barbui A, Puccini B, Miranda EC, Guida A, Federico M.
    PROGNOSTIC ROLE OF GENDER IN DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB CONTAINING REGIMENS: A FONDAZIONE ITALIANA LINFOMI/GRUPO DE ESTUDOS EM MOLÉSTIAS ONCO-HEMATOLÓGICAS RETROSPECTIVE STUDY.
    Leuk Lymphoma 54(1):53-7, 2013  
  173. Fianchi L, Criscuolo M, Breccia M, Maurillo L, Salvi F, Musto P, Mansueto G, Gaidano G, Finelli C, Aloe-Spiriti A, Santini V, Greco M, Hohaus S, Leone G, Voso MT.
    HIGH RATE OF REMISSIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA TREATED WITH 5-AZACYTIDINE: RESULTS OF AN ITALIAN RETROSPECTIVE STUDY.
    Leuk Lymphoma 54(3):658-61, 2013  
  174. Lobetti-Bodoni C, Ferrero D, Genuardi E, Passera R, Bernocco E, Sia D, Grignani G, Crisà E, Monitillo L, Rocci A, Drandi D, Giai V, Zanni M, Boi M, Isaia G, Barbero D, Lunghi M, Abruzzese E, Radaelli F, Pini M, Pregno P, Carlo-Stella C, Gaidano G, Boccadoro M, Ladetto M.
    TELOMERE LOSS IN PHILADELPHIA-NEGATIVE HEMATOPOIESIS AFTER SUCCESSFUL TREATMENT OF CHRONIC MYELOID LEUKEMIA: EVIDENCE FOR PREMATURE AGING OF THE MYELOID COMPARTMENT.
    Mech Ageing Dev 133(7):479-88, 2012  
  175. Dal Bo M, Bomben R, Zucchetto A, Del Poeta G, Gaidano G, Deaglio S, Efremov DG, Gattei V.
    MICROENVIRONMENTAL INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: HINTS FOR PATHOGENESIS AND IDENTIFICATION OF TARGETS FOR RATIONAL THERAPY.
    Curr Pharm Des 18(23):3323-34, 2012  
  176. Golay J, Semenzato G, Rambaldi A, Foà R, Gaidano G, Gamba E, Pane F, Pinto A, Specchia G, Zaja F, Regazzi M
    LESSONS FOR THE CLINIC FROM RITUXIMAB PHARMACOKINETICS AND PHARMACODYNAMICS.
    MAbs Aug 8;5(6), 2013  
  177. Bonetti P, Testoni M, Scandurra M, Ponzoni M, Piva R, Mensah AA, Rinaldi A, Kwee I, Tibiletti MG, Iqbal J, Greiner TC, Chan WC, Gaidano G, Piris MA, Cavalli F, Zucca E, Inghirami G, Bertoni F.
    DEREGULATION OF ETS1 AND FLI1 CONTRIBUTES TO THE PATHOGENESIS OF DIFFUSE LARGE B-CELL LYMPHOMA.
    Blood 122(13):2233-41, 2013  
  178. Chiappella A, Tucci A, Castellino A, Pavone V, Baldi I, Carella AM, Orsucci L, Zanni M, Salvi F, Liberati AM, Gaidano G, Bottelli C, Rossini B, Perticone S, De Masi P, Ladetto M, Ciccone G, Palumbo A, Rossi G, Vitolo U; Fondazione Italiana Linfomi.
    LENALIDOMIDE PLUS CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE AND RITUXIMAB IS SAFE AND EFFECTIVE IN UNTREATED, ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A PHASE I STUDY BY THE FONDAZIONE ITALIANA LINFOMI.
    Haematologica 98(11):1732-8, 2013  
  179. von Hohenstaufen KA, Conconi A, de Campos CP, Franceschetti S, Bertoni F, Margiotta Casaluci G, Stathis A, Ghielmini M, Stussi G, Cavalli F, Gaidano G, Zucca E.
    PROGNOSTIC IMPACT OF MONOCYTE COUNT AT PRESENTATION IN MANTLE CELL LYMPHOMA.
    Br J Haematol 162(4):465-73, 2013  
  180. Rinaldi A, Kwee I, Young KH, Zucca E, Gaidano G, Forconi F, Bertoni F.
    GENOME-WIDE HIGH RESOLUTION DNA PROFILING OF HAIRY CELL LEUKAEMIA.
    Br J Haematol 162(4):566-9, 2013  
  181. Sava GP, Speedy HE, Di Bernardo MC, Deaglio S, Karabon L, Frydecka I, Woszczyk D, Rossi D, Gaidano G, Mansouri L, Smedby KE, Juliusson G, Rosenquist R, Catovsky D, Houlston RS.
  182. RS2072135, A LOW-PENETRANCE VARIANT FOR CHRONIC LYMPHOCYTIC LEUKAEMIA?
  183. Br J Haematol 2013 162(2):221-8
     
  184. Rossi D, Ciardullo C, Gaidano G.
    GENETIC ABERRATIONS OF SIGNALING PATHWAYS IN LYMPHOMAGENESIS: REVELATIONS FROM NEXT GENERATION SEQUENCING STUDIES.
    Semin Cancer Biol 23(6):422-30  
  185. Rossi D, Spina V, Bomben R, Rasi S, Dal-Bo M, Bruscaggin A, Rossi FM, Monti S, Degan M, Ciardullo C, Serra R, Zucchetto A, Nomdedeu J, Bulian P, Grossi A, Zaja F, Pozzato G, Laurenti L, Efremov DG, Di-Raimondo F, Marasca R, Forconi F, Del Poeta G, Gaidano G, Gattei V.
    Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
    Blood 121(24):4902-5, 2013  
  186. Foà R, Del Giudice I, Guarini A, Rossi D, Gaidano G.
    Clinical implications of the molecular genetics of chronic lymphocytic leukemia.
    Haematologica, 98(5):675-85, 2013  
  187. Luminari S, Biasoli I, Arcaini L, Versari A, Rusconi C, Merli F, Spina M, Ferreri AJ, Zinzani PL, Gallamini A, Mastronardi S, Boccomini C, Gaidano G, D'Arco AM, Di Raimondo F, Carella AM, Santoro A, Musto P, Federico M.
    The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.
    Ann Oncol 24(8):2108-12, 2013  
  188. Federico M, Luminari S, Dondi A, Tucci A, Vitolo U, Rigacci L, Di Raimondo F, Carella AM, Pulsoni A, Merli F, Arcaini L, Angrilli F, Stelitano C, Gaidano G, Dell'olio M, Marcheselli L, Franco V, Galimberti S, Sacchi S, Brugiatelli M.
    R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi.
    J Clin Oncol 31(12):1506-13, 2013  
  189. Varettoni M, Zibellini S, Capello D, Arcaini L, Rossi D, Pascutto C, Rattotti S, Mangiacavalli S, Pochintesta L, Gotti M, Gaidano G, Cazzola M.
    Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.
    Leuk Lymphoma 54(11):2485-9, 2013  
  190. Rinaldi A, Capello D, Zucca E, Gaidano G, Bertoni F.
    Genome-wide DNA profiling of HIV-related B-cell lymphomas.
    Methods Mol Biol 973:213-26, 2013  
  191. Dal Bo M, Pozzo F, Bomben R, Degan M, Marconi D, Zucchetto A, Rossi D, Pozzato G, Zauli G, Gaidano G, Del Poeta G, Gattei V.
    ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells.
    Br J Haematol 161(4):596-9, 2013  
  192. Mian M, Rinaldi A, Mensah AA, Rossi D, Ladetto M, Forconi F, Marasca R, Uhr M, Stussi G, Kwee I, Cavalli F, Gaidano G, Zucca E, Bertoni F.
    Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.
    Ann Oncol 24(5):1378-84, 2013  
  193. Conconi A, Franceschetti S, Lobetti-Bodoni C, Stathis A, Margiotta-Casaluci G, Ramponi A, Mazzucchelli L, Bertoni F, Ghielmini M, Gaidano G, Cavalli F, Zucca E.
    Risk factors of central nervous system relapse in mantle cell lymphoma.
    Leuk Lymphoma, 54(9):1908-14, 2013  
  194. Brusa D, Serra S, Coscia M, Rossi D, D'Arena G, Laurenti L, Jaksic O, Fedele G, Inghirami G, Gaidano G, Malavasi F, Deaglio S.
    The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
    Haematologica, 98(6):953-63, 2013  
  195. Rizzo R, Audrito V, Vacca P, Rossi D, Brusa D, Stignani M, Bortolotti D, D' Arena G, Coscia M, Laurenti L, Forconi F, Gaidano G, Mingari MC, Moretta L, Malavasi F, Deaglio S.
    HLA-G is a component of the CLL escape repertoire to generate immune suppression: impact of HLA-G 14 bp (rs66554220) polymorphism.
    Haematologica, 2013 Dec 20. [Epub ahead of print]  
  196. Mian M, Kwee I, Rinaldi A, Ponzoni M, Bhagat G, Rossi D, Arcaini L, Gascoyne RD, Mollejo M, Baldini L, Thieblemont C, Gaidano G, Zucca E, Bertoni F.
    Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.
    Br J Haematol, 2013 Dec 11. doi: 10.1111/bjh.12688  
  197. Pozzo F, Dal Bo M, Peragine N, Bomben R, Zucchetto A, Rossi F, Degan M, Rossi D, Chiarenza A, Grossi A, Di Raimondo F, Zaja F, Pozzato G, Secchiero P, Gaidano G, Del Poeta G, Zauli G, Fo À R, Guarini A, Gattei V.
    Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.
    J Hematol Oncol 6:83, 2013  
  198. Della Starza I, Cavalli M, Del Giudice I, Barbero D, Mantoan B, Genuardi E, Urbano M, Mannu C, Gazzola A, Ciabatti E, Guarini A, Foà R, Galimberti S, Piccaluga P, Gaidano G, Ladetto M, Monitillo L.
    Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance.
    Hematol Oncol, 2013 Nov 19. doi: 10.1002/hon.2095  
  199. Maffei R, Fiorcari S, Bulgarelli J, Rizzotto L, Martinelli S, Rigolin GM, Debbia G, Castelli I, Bonacorsi G, Santachiara R, Forconi F, Rossi D, Laurenti L, Palumbo GA, Vallisa D, Cuneo A, Gaidano G, Luppi M, Marasca R.
    Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia.
    Exp Hematol S0301-472X(13)00816-3, 2013  
  200. Rossi FM, Zucchetto A, Tissino E, Dal Bo M, Bomben R, Caldana C, Pozzo F, Del Poeta G, Rossi D, Gaidano G, Gattei V.
    CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34+ hemopoietic progenitors cells.
    Leukemia 2013 Nov 8, in press  
  201. Arruga F, Gizdic B, Serra S, Vaisitti T, Ciardullo C, Coscia M, Laurenti L, D'Arena G, Jaksic O, Inghirami G, Rossi D, Gaidano G, Deaglio S.
    Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.
    Leukemia 2013 Oct 30, in press  
  202. Rossi D, Ciardullo C, Spina V, Gaidano G.
    Molecular bases of chronic lymphocytic leukemia in light of new treatments.
    Immunol Lett 155:51-5, 2013  
  203. Zucchetto A, Caldana C, Benedetti D, Tissino E, Rossi FM, Hutterer E, Pozzo F, Bomben R, Dal Bo M, D'Arena G, Zaja F, Pozzato G, Di Raimondo F, Hartmann TN, Rossi D, Gaidano G, Del Poeta G, Gattei V.
    CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
    Blood 122:3317-21, 2013  
  204. Morabito F, Mosca L, Cutrona G, Agnelli L, Tuana G, Ferracin M, Zagatti B, Lionetti M, Fabris S, Maura F, Matis S, Gentile M, Vigna E, Colombo M, Massucco C, Recchia AG, Bossio S, De Stefano L, Ilariucci F, Musolino C, Molica S, Di Raimondo F, Cortelezzi A, Tassone P, Negrini M, Monti S, Rossi D, Gaidano G, Ferrarini M, Neri A.
    Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Clin Cancer Res 19:5890-900, 2013  
  205. Del Giudice I, Chiaretti S, Santangelo S, Tavolaro S, Peragine N, Marinelli M, Ilari C, Raponi S, Messina M, Nanni M, Mauro FR, Piciocchi A, Bontempi K, Rossi D, Gaidano G, Guarini A, Foà R.
    Stereotyped subset #1 chronic lymphocytic leukemia: A direct link between BCR structure, function and patients' prognosis.
    Am J Hematol 2013, in press  
  206. Rossi D, Gaidano G.
    Richter syndrome.
    Adv Exp Med Biol 792:173-91, 2013  
  207. Chigrinova E, Rinaldi A, Kwee I, Rossi D, Rancoita PM, Strefford JC, Oscier D, Stamatopoulos K, Papadaki T, Berger F, Young KH, Murray F, Rosenquist R, Greiner TC, Chan WC, Orlandi EM, Lucioni M, Marasca R, Inghirami G, Ladetto M, Forconi F, Cogliatti S, Votavova H, Swerdlow SH, Stilgenbauer S, Piris MA, Matolcsy A, Spagnolo D, Nikitin E, Zamò A, Gattei V, Bhagat G, Ott G, Zucca E, Gaidano G, Bertoni F.
    Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.
    Blood 122:2673-82, 2013  
  208. Rinaldi A, Mensah AA, Kwee I, Forconi F, Orlandi EM, Lucioni M, Gattei V, Marasca R, Berger F, Cogliatti S, Cavalli F, Zucca E, Gaidano G, Rossi D, Bertoni F.
    Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
    Br J Haematol 163:194-204; 2013  
  209. Mian M, Capello D, Ventre MB, Grazio D, Svaldi M, Rossi A, Tsang R, Gospodarowicz MK, Oldani E, Federico M, Luminari S, Marcheselli L, Pogliani EM, Rossini F, Cabrera ME, Martelli M, Gutierrez-Garcia G, Busetto M, Visco C, Fiegl M, Rossi D, Gaidano G, Cavalli F, Zucca E, Rambaldi A, Cortelazzo S; on behalf of the International Extranodal Lymphoma Study Group (IELSG).
    Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study).
    Ann Hematol 2013, in press  
  210. Efficace F, Gaidano G, Sprangers M, Cottone F, Breccia M, Voso MT, Caocci G, Stauder R, Di Tucci AA, Sanpaolo G, Selleslag D, Angelucci E, Platzbecker U, Mandelli F.
    Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.
    Ann Oncol 25:447-454, 2014  
  211. Monti S, Deambrogi C, Rinaldi A, Bertoni F, Gaidano G, Rossi D.
    MYC network mutations in high-risk chronic lymphocytic leukaemia.
    Hematol Oncol 2014, in press; doi: 10.1002/hon.2117  
  212. Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, Ouillette P, Trifonov V, Rossi D, Tabbò F, Ponzoni M, Chadburn A, Murty VV, Bhagat G, Gaidano G, Inghirami G, Malek SN, Rabadan R, Dalla-Favera R.
    Genetics of follicular lymphoma transformation.
    Cell Rep 6:130-40, 2014  
  213. Palumbo A, Bringhen S, Larocca A, Rossi D, Di Raimondo F, Magarotto V, Patriarca F, Levi A, Benevolo G, Vincelli ID, Grasso M, Franceschini L, Gottardi D, Zambello R, Montefusco V, Falcone AP, Omedé P, Marasca R, Morabito F, Mina R, Guglielmelli T, Nozzoli C, Passera R, Gaidano G, Offidani M, Ria R, Petrucci MT, Musto P, Boccadoro M, Cavo M.
    Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival.
    J Clin Oncol 2014 Jan 21; in press  
  214. Rossi D, Khiabanian H, Spina V, Ciardullo C, Bruscaggin A, Famà R, Rasi S, Monti S, Deambrogi C, De Paoli L, Wang J,Gattei V, Guarini A, Foà R, Rabadan R, Gaidano G.
    CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Blood, in press, 2014  
  215. Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Hu K, Woodard P, Yang AS, Kantarjian HM.
    Results of a Randomized, Double-Blind Study of Romiplostim Versus Placebo in Patients with Low or Int-1 Risk MDS and Thrombocytopenia
    Cancer, in press, 2014  
  216. Burkhard R, Bhagat G, Cogliatti SB, Rossi D, Gaidano G, Pasqualucci L, Novak U.
    BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Br J Haematol, in press, 2014  
  217. Messina M, Del Giudice I, Khiabanian H, Rossi D, Chiaretti S, Rasi S, Spina V, Holmes AB, Marinelli M, Fabbri G, Piciocchi A, Mauro FR, Guarini A, Gaidano G, Dalla-Favera R, Pasqualucci L, Rabadan R, Foà R.
    GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC EUKEMIA CHEMO-REFRACTORINESS
    Blood, in press, 2014  
  218. Bulian P, Shanafelt TD, Fegan C, Zucchetto A, Cro L, Nückel H, Baldini L, Kurtova AV, Ferrajoli A, Burger JA, Gaidano G, Del Poeta G, Pepper C, Rossi D, Gattei V.
    CD49d Is the Strongest Flow Cytometry-Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia.
    J Clin Oncol, in press, 2014
This is Schools Diazo Plone Theme